 |
|||||||||
|
 |
 |
 |
 |
 |
|
|||
|
|||||||||
| |||||||||
|
||||||||||||||||||||||||||||||||||
|
Patient Management/TreatmentThe CDC-recommended therapeutics for the treatment of bacterial vaginosis in non-pregnant women includes both oral and intravaginal preparations.
Recommended Regimens
Metronidazole 500 mg orally twice a day for 7 days, OR Metronidazole gel 0.75%, one full applicator (5 g) intravaginally, once a day for 5 days, OR Clindamycin cream 2%, one full applicator (5 g) intravaginally at bedtime for 7 days Alternative Regimens Clindamycin 300 mg orally twice a day for 7 days, OR Clindamycin ovules 100 g intravaginally once at bedtime for 3 days Multiple recurrences Metronidazole gel 0.75%, one full applicator (5 g) intravaginally,twice weekly for 4 months may reduce recurrences PregnancyThe CDC-recommended therapeutics for the treatment of bacterial vaginosis in pregnancy includes only oral preparations. Pregnant women with symptomatic disease should be treated with:
Metronidazole 500 mg orally twice a day for 7 days,
OR Metronidazole 250 mg orally three times a day for 7 days, OR Clindamycin 300 mg orally twice a day for 7 days
Page 22 of 26
    |
